PDE3A and cancer: Hypermethylation of the phosphodiesterase 3A (PDE3A) gene correlates with cisplatin resistance, and the epigenetic activation of forkhead box protein F1 (FOXF1) confers cancer stem cell properties to cisplatin resistance [115,116].